Top 10 companies in competent cells market

The Competent Cells Market is expected to grow at a CAGR of 10.0% from 2018 to 2023 to reach USD 2,318.6 million by 2023. Cloning is a process used to produce genetically identical copies of a biological entity. These copies are referred to as clones. Since last decade, researchers are cloning a wide range of biological material namely genes, cells, tissues, or entire organisms. For this, the natural competence of a cell or bacteria or genome is highly important i.e. it must possess the ability to take up the external DNA naturally.

However, with some organism’s inability to take up the external DNA and limitations associated with natural competence have led to the development of artificially competent cells. These artificial competent cells increase the reliability and efficiency of transformation based experiments. Further, researchers used this artificially mediated transformation for repairing genes and thereby contribute to genome maintenance or acquisition of genetic diversity.

Here are the top 10 companies operating in the Competent Cells Market

Thermo Fisher Scientific (U.S.)

Founded in 2006 and headquartered at Waltham, Massachusetts, U.S.; Thermo Fisher Scientific Inc. was formed by the merger of Thermo Electron and Fisher Scientific. Thermo Fisher Scientific Inc. is engaged in providing analytical instruments, reagents & consumables, and software & services for research, manufacturing, analysis, discovery, and diagnosis under the brands Unity Lab Services, Thermo Scientific, Applied Biosystems, Invitrogen, and Fisher Scientific worldwide. The company offers competent cells through its subsidiary Life Technologies.

With its many subsidiaries and a strong network of distributors, the company has its presence across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Agilent Technologies (U.S.)

Founded in 1999 and headquartered at Santa Clara, California, U.S.; Agilent Technologies, Inc. is engaged in life sciences, applied chemical markets, and diagnostics. The company operates through three business segments namely, Life Sciences & Applied Markets, Agilent CrossLab, and Diagnostics and Genomics. The company provides competent cells under the Agilent CrossLab business segment.

With its subsidiaries and a strong network of distributors, the company has its presence across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Merck & Co. (U.S.)

Founded in 1891 and headquartered at New Jersey, U.S.; Merck & Co., Inc. is engaged in delivering innovative health solutions in the form of prescription medicines, biologic therapies, and animal healthcare products.

The company provides competent cells through its subsidiary, Merck Millipore, under its Life Sciences research business segment.

With many subsidiaries and a strong network of distribution, the company has its presence in the North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Bio-Rad Laboratories Inc. (U.S.)

Founded in 1952 and headquartered at Hercules, California, U.S.; Bio-Rad Laboratories, Inc. is engaged in providing instruments, consumables, software, reagents, and content for the areas of protein quantitation, cell biology, food safety, protein purification, gene expression, drug discovery & manufacture, and science education.

The company provides competent cells under Life Science business segment. With its subsidiaries and strong network of distributors, the company has its presence across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Illumina Inc. (U.S.)

Founded in 1998 and headquartered at San Diego, U.S.; Illumina, Inc. serves in the life science, translational and clinical genomics; reproductive and genetic health and oncology. The company offers products to genomic research centers, government laboratories, academics institutions as well as biotechnology, pharmaceutical, agrigenomics, and commercial molecular diagnostics laboratories.

The company provides competent cells under Genomic Library Construction Kits, and Gene & PCR Cloning Kits through its subsidiary, Epicentre. With its subsidiaries and a strong network of distributors, the company has its presence across North America, Europe, Latin America & Asia-pacific and others.

Meticulous Research in its latest publication on Competent Cells Market has predicted the growth of 10% during the forecast year 2018-2023.

Quiagen N.V. (Netherlands)

Founded in 1984 and headquartered at Venlo, The Netherlands.; Qiagen N.V. is engaged in providing solutions in transforming biological samples into valuable molecular insights. The company offers products such as consumables, automated instrumentation systems, and bioinformatics to four customer classes such as Molecular Diagnostics, Pharma, Academia, and Applied Testing.

The company provides competent cells under consumables and related revenues product category. With its subsidiaries and a strong network of distributors, the company has its presence across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Takara Holdings Inc. (Japan)

Founded in 1842 and headquartered at Shimogyo-ku, Kyoto, Japan; Takara Holdings Inc. is providing safe and reliable products and services backed up by the latest technologies. The company operates through three business segments, the Takara Shuzo Group, the Takara Bio Group, and the Takara Healthcare.

The company provides competent cells through its subsidiary, Takara Bio Group, under the brands namely, Takara, Cellartis, and Clontech. With its subsidiaries and a strong network of distributors, the company has its presence across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Meridian Bioscience, Inc. (U.S.)

Founded in 1977 and headquartered at Ohio, U.S.; Meridian Bioscience, Inc. is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of diagnostic test kits for certain viral, gastrointestinal, respiratory, parasitic infectious diseases, and elevated blood lead levels.

The company provides competent cells under Life Science business segment. With its subsidiaries and strong network of distribution, the company has its presence across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

GenScript Biotech Corporation (U.S.)

Founded in 2002 and headquartered at New Jersey, U.S; GenScript Biotech Corporation is engaged in providing well-recognized life sciences research & application service. The company operates through four business segments, namely, life sciences research services, life sciences research catalog products, industrial synthetic biology products, and preclinical drug development services.

The company provides competent cells under Life sciences research catalog products segment. With its subsidiaries and strong network of distributors, the company has its presence across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Promega Corporation

Founded in 1978 and headquartered at Madison, WI, U.S.; Promega Corporation provides products in the field of genomics, protein analysis & expression, cellular analysis, and drug discovery & genetic identity. In addition, the company offers innovative solutions and technical support to researchers, analysts, and technicians in the life sciences, industry and government by offering numerous products in the fields of genomics, cellular analysis, proteomics, human identification, molecular diagnostics, and applied biotechnology.

With its subsidiaries and strong network of distribution, the company has its presence in more than 100 countries.

Popular Mentions: OriGene Technologies, Inc. (U.S.), Cell Applications, Inc. (U.S.), Delphi Genetics S.A. (Belgium), New England Biolabs (U.S.), Scarab Genomics, LLC (U.S.), Zymo Research Corp. (U.S.

Authoritative Research on the Competent Cells Market – Global Opportunity Analysis and Industry Forecast (2018-2023)

Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:

• Recent financial performance
• Key products
• Significant company strategies
• Partnerships and acquisitions

Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.